Rubio-Gayarre A, Vinyoles M, Tejedor JR, Guerrero-Murillo M, et al. The NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab. Blood 2026;148:2013-2028.
PMID: 42345361